You'll continue to hear buzz about Avandia (rosiglitazone)

You'll continue to hear buzz about Avandia (rosiglitazone).

Availability. Avandia will be back on pharmacy that FDA will loosen its restrictions.

FDA says there's not enough evidence that Avandia increases the risk of heart attacks...even though some experts disagree.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote